FRI0448 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Psoriatic Arthritis: 2-Year Efficacy and Safety Results from The Phase 3 Randomised, Double-Blind, Placebo-Controlled Trial, Future 1

A. Kavanaugh; P. Mease; A. Reimold; H. Tahir; J. Rech; S. Hall; P. Geusens; Z. Wang; S. Mpofu;

doi:10.1136/annrheumdis-2016-eular.3565

FRI0448 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Psoriatic Arthritis: 2-Year Efficacy and Safety Results from The Phase 3 Randomised, Double-Blind, Placebo-Controlled Trial, Future 1

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3565 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 598.1-598 ◽

Cited By ~ 1

Author(s):

A. Kavanaugh ◽

P. Mease ◽

A. Reimold ◽

H. Tahir ◽

J. Rech ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Controlled Trial ◽

Signs And Symptoms ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

929g Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(14)60571-0 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-160 ◽

Cited By ~ 2

Author(s):

Yan Yiannakou ◽

Michel Bouchoucha ◽

Ingolf Schiefke ◽

Hubert Piessevaux ◽

Rafal Filip ◽

...

Keyword(s):

Chronic Constipation ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Results of a global phase 3, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of sebelipase alfa as an enzyme replacement therapy in children and adults with lysosomal acid lipase deficiency

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2014.12.042 ◽

2015 ◽

Vol 114 (2) ◽

pp. S27

Author(s):

Barbara Burton

Keyword(s):

Enzyme Replacement Therapy ◽

Replacement Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Acid Lipase ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Lysosomal Acid ◽

Enzyme Replacement

Download Full-text

PWE-252 Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomised, double-blind, placebo-controlled trial

Gut ◽

10.1136/gutjnl-2015-309861.698 ◽

2015 ◽

Vol 64 (Suppl 1) ◽

pp. A323.2-A324

Author(s):

Y Yiannakou ◽

M Bouchoucha ◽

I Schiefke ◽

H Piessevaux ◽

R Filip ◽

...

Keyword(s):

Chronic Constipation ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial

Arthritis Research & Therapy ◽

10.1186/s13075-020-2126-1 ◽

2020 ◽

Vol 22 (1) ◽

Author(s):

Philip Mease ◽

M. Elaine Husni ◽

Shelly Kafka ◽

Soumya D. Chakravarty ◽

Diane D. Harrison ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Radiographic Progression ◽

Controlled Trial ◽

Composite Index ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

228. Secukinumab, A Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicentre, Double-Blind, Placebo-Controlled Study

Rheumatology ◽

10.1093/rheumatology/kev089.115 ◽

2015 ◽

Keyword(s):

Monoclonal Antibody ◽

Psoriatic Arthritis ◽

Radiographic Progression ◽

Safety Data ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 17A

Download Full-text

SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1996 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A674.2-A675

Author(s):

A. Kavanaugh ◽

I. B. McInnes ◽

A. B. Gottlieb ◽

L. Puig ◽

P. Rahman ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020573.793488590 ◽

2013 ◽

Author(s):

Kamran Ghoreschi

Keyword(s):

Psoriatic Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718257967.793494565 ◽

2014 ◽

Author(s):

Christian Jorgensen ◽

Yves-Marie Pers

Keyword(s):

Monoclonal Antibody ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Factor Therapy ◽

Necrosis Factor

Download Full-text

A phase 3 multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Sufentanil NanoTab PCA System for the treatment of post-operative pain after open abdominal surgery

Journal of Pain ◽

10.1016/j.jpain.2013.01.671 ◽

2013 ◽

Vol 14 (4) ◽

pp. S83

Author(s):

M. Royal ◽

H. Minkowitz ◽

F. Ringold ◽

T. Gan ◽

P. Palmer

Keyword(s):

Abdominal Surgery ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Operative Pain ◽

Open Abdominal Surgery

Download Full-text

OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.3096 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 136.1-136 ◽

Cited By ~ 3

Author(s):

A. Kavanaugh ◽

L. Puig ◽

A.B. Gottlieb ◽

C. Ritchlin ◽

Y. You ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Controlled Study ◽

Joint Involvement ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text